Literature DB >> 1366621

The in vivo application of ribozymes.

M Cotten1.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 1366621     DOI: 10.1016/0167-7799(90)90168-w

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


× No keyword cloud information.
  9 in total

1.  Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.

Authors:  N R Taylor; B E Kaplan; P Swiderski; H Li; J J Rossi
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

2.  Assaying synthetic ribozymes in plants: high-level expression of a functional hammerhead structure fails to inhibit target gene activity in transiently transformed protoplasts.

Authors:  L Mazzolini; M Axelos; N Lescure; P Yot
Journal:  Plant Mol Biol       Date:  1992-11       Impact factor: 4.076

Review 3.  Antisense and ribozyme constructs in transgenic animals.

Authors:  D L Sokol; J D Murray
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

Review 4.  Antiviral ribozymes. New jobs for ancient molecules.

Authors:  A Menke; G Hobom
Journal:  Mol Biotechnol       Date:  1997-08       Impact factor: 2.695

5.  Strategies for the suppression of peroxidase gene expression in tobacco. I. Designing efficient ribozymes.

Authors:  C L McIntyre; J M Manners
Journal:  Transgenic Res       Date:  1996-07       Impact factor: 2.788

Review 6.  Inhibition of gene expression with ribozymes.

Authors:  P Marschall; J B Thomson; F Eckstein
Journal:  Cell Mol Neurobiol       Date:  1994-10       Impact factor: 5.046

Review 7.  Anti-HIV ribozymes.

Authors:  L Q Sun; J A Ely; W Gerlach; G Symonds
Journal:  Mol Biotechnol       Date:  1997-06       Impact factor: 2.860

8.  Selective cleavage of closely-related mRNAs by synthetic ribozymes.

Authors:  M J Bennett; J V Cullimore
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

9.  Expression of a chimeric ribozyme gene results in endonucleolytic cleavage of target mRNA and a concomitant reduction of gene expression in vivo.

Authors:  P Steinecke; T Herget; P H Schreier
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.